|
TRPC4AP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.417500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.636690E-03 |
| Normal-vs-Stage2 |
9.362500E-02 |
| Normal-vs-Stage3 |
7.066200E-02 |
| Normal-vs-Stage4 |
2.313800E-01 |
| Stage1-vs-Stage2 |
8.657800E-01 |
| Stage1-vs-Stage3 |
3.925400E-01 |
| Stage1-vs-Stage4 |
4.361800E-01 |
| Stage2-vs-Stage3 |
6.823800E-01 |
| Stage2-vs-Stage4 |
6.624400E-01 |
| Stage3-vs-Stage4 |
8.960400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.624800E-03 |
| Normal-vs-AfricanAmerican |
1.960470E-03 |
| Normal-vs-Asian |
3.416700E-04 |
| Caucasian-vs-AfricanAmerican |
2.591600E-01 |
| Caucasian-vs-Asian |
4.144000E-02 |
| AfricanAmerican-vs-Asian |
6.963400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.041100E-03 |
| Normal-vs-Female |
7.562100E-03 |
| Male-vs-Female |
3.501400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.179300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.586200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.757420E-01 |
| Normal-vs-Age(81-100Yrs) |
6.011800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.686760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.518200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.542600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.126600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.275000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.071800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.756990E-01 |
| Classical-VS-Follicular |
2.638200E-02 |
| Classical-VS-Other |
3.851900E-02 |
| Classical-VS-Normal |
7.64000000000875E-05 |
| Tall-VS-Follicular |
6.620000E-01 |
| Tall-VS-Other |
1.478430E-01 |
| Tall-VS-Normal |
3.322600E-01 |
| Follicular-VS-Other |
4.083200E-01 |
| Follicular-VS-Normal |
6.255400E-01 |
| Other-VS-Normal |
1.880590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.544900E-03 |
| Normal-vs-N1 |
6.110200E-01 |
| N0-vs-N1 |
2.294800E-01 |
|
|
